MERA Yukinori | Japan Pharmaceutical Manufactures Association
スポンサーリンク
概要
関連著者
-
Hashimoto Masaharu
Japan Pharmaceutical Manufacturers Association
-
AZE Yoshiya
Japan Pharmaceutical Manufactures Association, Tokyo, Japan
-
IWAI Hisakazu
Japan Pharmaceutical Manufacturers Association
-
NAESHIRO Ichiro
Japan Pharmaceutical Manufacturers Association
-
FUKAZAWA Hirofumi
Japan Pharmaceutical Manufacturers Association
-
AOKI Toyohiko
Japan Pharmaceutical Manufacturers Association
-
MERA Yukinori
Japan Pharmaceutical Manufactures Association
-
Fukazawa Hirofumi
Pfizer Health Academy Pfizer Pharmaceuticals Inc.
-
Aze Yoshiya
Japan Pharmaceutical Manufacturers Association
-
IWAI Hisakazu
Safety Assessment Group, Central Research Laboratory, Sanwa Kagaku Kenkyusho Co., Ltd.
-
KIMURA TAKASHI
Japan Pharmaceutical Manufacturers Association
-
MASUMOTO YOSHIHIRO
Japan Pharmaceutical Manufacturers Association
-
Kawahara Junichi
Japan Pharmaceutical Manufacturers Association
-
AOKI Yasuji
Research and Development Division, Hokuriku Seiyaku Co., Ltd.
-
MOMOSE Yasunori
Japan Pharmaceutical Manufacturers Association
-
ISHIZUKA Shuji
Japan Pharmaceutical Manufacturers Association
-
YAMAMOTO Mitsuo
Japan Pharmaceutical Manufacturers Association
-
KAWAHARA Jun-ichi
Japan Pharmaceutical Manufacturers Association
-
TAKASHITA Hisahsi
Japan Pharmaceutical Manufacturers Association
-
NAKANO Kazuyuki
Japan Pharmaceutical Manufactures Association
-
KOBAYASHI Yujirou
Japan Pharmaceutical Manufactures Association
-
WACHI Masayuki
Japan Pharmaceutical Manufactures Association
-
HAYASHI Mariko
Japan Pharmaceutical Manufactures Association
-
MORITA Nobuko
Japan Pharmaceutical Manufactures Association
-
Aoki Yasuji
Japan Pharmaceutical Manufacturers Association
-
Iwai Hisakazu
Safety Assessment Group Central Research Laboratory Sanwa Kagaku Kenkyusho Co. Ltd.
-
Hayashi Mariko
Japan Pharmaceutical Manufacturers Association
-
Kimura Takashi
Japan Atomic Energy Agency Tokai Reprocessing Technology Development Center
著作論文
- P-60 Current Status of Hematology in General Toxicity Studies for Pharmaceuticals.(Proceedings of the 27th Annual Meeting)
- P-59 Current Status of Clinical Chemistry in General Toxicology Studies for Pharmaceuticals.(Proceedings of the 27th Annual Meeting)